Frequency of optimal follow-up in patients with risk factors for MGUS progression
| Type of follow-up received . | M spike ≥ 1.5 g/dL and/or non-IgG spike (n = 64; 59%) . | M spike < 1.5 g/dL and IgG spike (n = 42; 39%) . | P . |
|---|---|---|---|
| Optimal | 52 (81%) | 27 (64%) | .07 |
| Suboptimal | 12 (19%) | 15 (36%) |
| Type of follow-up received . | M spike ≥ 1.5 g/dL and/or non-IgG spike (n = 64; 59%) . | M spike < 1.5 g/dL and IgG spike (n = 42; 39%) . | P . |
|---|---|---|---|
| Optimal | 52 (81%) | 27 (64%) | .07 |
| Suboptimal | 12 (19%) | 15 (36%) |
Patients with high-risk features for MGUS progression were more likely to receive an optimal follow-up compared with low-risk patients.